Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RM-131 in Diabetic Gastroparesis
NCT01571297Phase 2Completed
- Sponsor
- Motus Therapeutics, Inc.
- Start
- Apr 2012
- Primary completion
- Aug 2013
- Modality
- Peptides, Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of relamorelin in diabetic gastroparesis, sponsored by Motus Therapeutics, Inc.. Started Apr 2012; status: completed.
02
Drugs
relamorelin
03
Conditions
diabetic gastroparesis
Beyond the preview
Go deeper on NCT01571297.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01571297.